Related references
Note: Only part of the references are listed.
Review
Microbiology
Alessandro G. Carabelli et al.
Summary: The emergence of the SARS-CoV-2 variants of concern (VOCs) in late 2020 marked a major change in the virus's adaptation to humans, resulting in increased transmission rates and ability to evade immune responses. These VOCs, designated Alpha, Beta, Gamma, Delta, and Omicron, rapidly became dominant globally, outcompeting previous variants. The success of VOCs can be attributed to the altered properties of the virus and changes in antigenicity, influenced by both vaccination and prior infection.
NATURE REVIEWS MICROBIOLOGY
(2023)
Article
Microbiology
Xu Zhong et al.
Summary: This study assessed the performance of the rapid antigen detection test (RADT) and found that Ediagnosis performed excellently in individuals with a higher viral load, individuals in the early symptomatic phase, and especially those with upper respiratory tract symptoms.
MICROBIOLOGY SPECTRUM
(2023)
Article
Infectious Diseases
Linus Bornemann et al.
Summary: The study aimed to assess the impact of different variants of concern (VOCs) on the clinical performance of an antigen rapid diagnostic test (Ag-RDT). The results showed that the sensitivity of the Ag-RDT was dependent on viral load, gender, and age. The Omicron variant had lower sensitivity compared to the wild-type samples, with a higher limit of detection.
CLINICAL MICROBIOLOGY AND INFECTION
(2023)
Article
Infectious Diseases
Jannik Stemler et al.
Summary: A prevalence investigation using rapid antigen testing found a more than twofold higher prevalence of SARS-CoV-2 infection compared to governmental reports in Germany. Out of 419 valid test results, 7 (1.67%) were positive, and three positive individuals were not included in the governmental statistics as they did not have a PCR test.
Article
Virology
Yuko Sakai-Tagawa et al.
Summary: Diagnosis by rapid antigen tests (RATs) is useful for early initiation of antiviral treatment. However, the sensitivity of RATs may be affected by amino acid changes in the N protein, particularly in the Omicron variant and its subvariants.
JOURNAL OF MEDICAL VIROLOGY
(2023)
Article
Infectious Diseases
Roderick P. Venekamp et al.
Summary: The performances of three commonly used antigen rapid diagnostic tests used as self-tests in asymptomatic individuals were assessed during the Omicron period. The sensitivities of these tests were found to be very low. Repeated self-testing and testing when symptoms develop are recommended.
CLINICAL MICROBIOLOGY AND INFECTION
(2023)
Letter
Microbiology
Joshua Deerain et al.
JOURNAL OF CLINICAL MICROBIOLOGY
(2022)
Article
Immunology
Andreas Osterman et al.
Summary: This study evaluated the performance of nine SARS-CoV-2 rapid antigen tests (RATs) in a single-centre laboratory study. The results showed that higher virus loads were required for omicron-containing samples compared to delta-containing samples in order to test positive in these point-of-care tests. However, testing of expanded virus stocks suggested a comparable RAT sensitivity for both omicron and delta variants, questioning the predictive value of in vitro studies for clinical performance. Given the importance of RATs in national testing strategies during the omicron wave, awareness must be increased for the reduced detection rate of omicron infections by RATs and a short list of suitable RATs should be disclosed.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY
(2022)
Article
Multidisciplinary Sciences
Delphine Planas et al.
Summary: The Omicron variant of SARS-CoV-2, identified in November 2021, has spread rapidly worldwide and shows resistance to most therapeutic monoclonal antibodies and vaccine-elicited antibodies. However, it can be neutralized by antibodies generated by a booster vaccine dose.
Article
Multidisciplinary Sciences
Sandile Cele et al.
Summary: The study found that the Omicron variant has reduced neutralizing effectiveness in individuals vaccinated with Pfizer BNT162b2, but those who had previously been infected with SARS-CoV-2 showed better neutralization against Omicron.
Article
Biochemistry & Molecular Biology
Paul R. Wratil et al.
Summary: This study reports on the dynamics of neutralizing antibodies in individuals convalescing from coronavirus disease 2019 or who are vaccine-naive and subsequently vaccinated. The findings suggest that infection-plus-vaccination-induced hybrid immunity or triple immunization can induce high-quality antibodies with superior neutralization capacity against variants of concern, including omicron.
Article
Medicine, General & Internal
Lisa J. Krueger et al.
Summary: This study evaluated the clinical performance and ease-of-use of seven SARS-CoV-2 antigen-detecting rapid diagnostic tests (Ag-RDTs). The results showed high sensitivity and specificity of the Ag-RDTs, especially in early-stage disease and individuals with high viral loads. The tests from Mologic, Bionote, and Standard Q demonstrated good usability.
Letter
Microbiology
Sydney Stanley et al.
JOURNAL OF CLINICAL MICROBIOLOGY
(2022)
Review
Oncology
Annika Fendler et al.
Summary: The efficacy and immunogenicity of COVID-19 vaccines in cancer patients are uncertain due to their exclusion from pivotal clinical trials. In this Review, the current knowledge on vaccine efficacy and immune responses in cancer patients is summarized, highlighting key factors that may affect vaccine efficacy in this population.
NATURE REVIEWS CLINICAL ONCOLOGY
(2022)
Article
Medicine, General & Internal
Sergei A. Kiryanov et al.
Summary: This study compared the diagnostic performance of different upper respiratory tract samples for the direct RT-PCR detection of SARS-CoV-2. The results showed that nasal swab and saliva samples tested by direct RT-PCR had sufficient sensitivity and can be acceptable alternatives for rapid detection of SARS-CoV-2 infections.
Review
Infectious Diseases
J. M. Jabs et al.
Summary: Routine screening of asymptomatic healthcare workers can help interrupt chains of infection through early detection, but the heterogeneous proportions may be explained by regional differences and pre-analytical pitfalls.
BMC INFECTIOUS DISEASES
(2022)
Article
Infectious Diseases
Daniel Baird et al.
Summary: The study aimed to validate the functionality of the NeuMoDx(TM) SARS-CoV-2 assay, evaluate its performance in off-label collection media, and assess cross-reactivity with other respiratory viruses. The results showed that the NeuMoDx assay exhibited high sensitivity and specificity, and did not cross-react with other respiratory viruses.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
(2022)
Article
Microbiology
Chee Wah Tan et al.
Summary: The study found that the Omicron variant of SARS-CoV-2 can escape neutralizing antibodies against the ancestral virus. Bat and pangolin sarbecoviruses showed less neutralization escape compared to the Omicron variant. This suggests that SARS-CoV-2 variants are evolving differently from animal sarbecoviruses under immune selection pressure.
NATURE MICROBIOLOGY
(2022)
Article
Medicine, General & Internal
Paul K. Drain et al.
Summary: This diagnostic study assessed the accuracy of two rapid diagnostic tests for detecting SARS-CoV-2 across different variants. The results showed that both tests had reliable analytical and clinical performance data across the different variant phases. Therefore, home-based rapid antigen testing programs may play an important role in reducing the global transmission of SARS-CoV-2.
Letter
Medicine, General & Internal
Peter Bogaty et al.
Summary: The author raises important questions regarding rapid diagnostic testing for SARS-CoV-2, including the impact of vaccination on quarantine requirements and the duration of positive results from nucleic acid amplification tests.
NEW ENGLAND JOURNAL OF MEDICINE
(2022)
Article
Multidisciplinary Sciences
Nina Koerber et al.
Summary: Anti-viral immunity declines over time after SARS-CoV-2 infection, but convalescents can achieve enhanced immune response through vaccination. Virus-specific antibody titers decline rapidly, while virus-specific polyfunctional T cells persist.
NATURE COMMUNICATIONS
(2022)
Article
Immunology
Marc Lipsitch et al.
Summary: The study evaluates the impact of breakthrough SARS-CoV-2 infections in vaccinated individuals and discusses the challenges in measuring breakthrough infections and determining the factors affecting vaccine effectiveness. The research also addresses key questions on transitioning to endemicity, tracking viral variants, identifying immune correlates of protection, and dealing with public health challenges in countering breakthrough infections amid global vaccine shortages.
NATURE REVIEWS IMMUNOLOGY
(2022)
Article
Immunology
Tobias Weinberger et al.
Summary: During the first wave of the pandemic in southern Germany, frontline healthcare workers faced an increased risk of SARS-CoV-2 infection, highlighting the need for stringent infection control measures to protect all patient-facing staff.
CLINICAL INFECTIOUS DISEASES
(2021)
Letter
Microbiology
Christopher M. Chandler et al.
JOURNAL OF CLINICAL MICROBIOLOGY
(2021)
Article
Virology
Florian Hitzenbichler et al.
Summary: This study compared the diagnostic performance of throat washings (TW), nasopharyngeal swabs (NS) and oropharyngeal swabs (OS) in detecting SARS-CoV-2 RNA. Nasopharyngeal swabs showed higher concentrations and diagnostic sensitivities, with significant concentration differences between NS and TW. Oropharyngeal swabs (OS) and throat washings (TW) can still be considered for SARS-CoV-2 diagnostics, albeit with slightly lower concentrations.
Article
Infectious Diseases
Sabrina Jegerlehner et al.
Summary: The study assessed the accuracy of rapid antigen testing for diagnosing SARS-CoV-2 infection in a primary/secondary care testing facility. The results showed that the sensitivity of rapid antigen tests was lower than expected, potentially leading to individuals being falsely classified as negative.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
(2021)
Review
Microbiology
William T. Harvey et al.
Summary: The evolution of SARS-CoV-2 has been characterized by the emergence of mutations and variants that impact virus characteristics. Manufacturers are preparing for possible updates to vaccines in response to changes in the virus population, and it is crucial to monitor genetic and antigenic changes alongside experiments to understand the impacts of mutations.
NATURE REVIEWS MICROBIOLOGY
(2021)
Article
Medicine, General & Internal
M. G. Thompson et al.
Summary: A study with a test-negative design analyzed 41,552 admissions to 187 hospitals and 21,522 visits to 221 EDs or urgent care clinics. The mRNA-based vaccines (>= 14 days after the second dose) were highly effective against SARS-CoV-2 infection leading to hospitalization (89%), ICU admission (90%), or an urgent care visit (91%).
NEW ENGLAND JOURNAL OF MEDICINE
(2021)
Letter
Medicine, General & Internal
Josh Torgovnick
NEW ENGLAND JOURNAL OF MEDICINE
(2021)
Article
Infectious Diseases
Victor M. Corman et al.
Summary: This study compared the analytical sensitivity and specificity of seven commercially available antigen point-of-care test devices, showing that most devices have sensitivity overlapping with SARS-CoV-2 viral loads typically observed during the first week of symptoms, marking the infectious period in most patients. Antigen point-of-care tests with detection limits approximating virus concentrations at which patients are infectious may streamline decision-making in healthcare and public health.
Article
Medicine, General & Internal
Marjolein F. Q. Kluytmans-van Den Bergh et al.
